Hyperfine

Guilford, CT  All United States companies → Founded 2014
Imaging AI Specialist Medical Device / Hardware Point-of-Care Diagnostics
Emergency Medicine General Surgery Internal Medicine Neurology
Clinical Decision Support & Reference Neurology AI Radiology & Imaging AI
Public (Nasdaq: HYPR) — Over $423M (initial funding rounds including SPAC merger and private placement by Dec 2021) + $20M+ (equity Oct 2025) + up to $40M (debt facility March 2026, with $15M drawn initially)

Products

Swoop Point-of-Care Magnetic Resonance Imaging (POC MRI) Scanner
Hyperfine
Neurology AI
The Hyperfine Swoop Point-of-Care (POC) MRI Scanner is the world's first FDA-cleared, portable, ultra-low-field magnetic resonance brain imaging system, bringing diagnostic-quality brain imaging directly to the patient's bedside with AI-powered software.
Swoop® Portable MR Imaging System™
Hyperfine
Neurology AI
The Hyperfine Swoop® Portable MR Imaging System™ is an FDA-cleared, AI-powered, ultra-low-field portable MRI device for brain imaging at the point of care, designed to increase accessibility and facilitate rapid diagnosis in various clinical settings.
Swoop Portable MR Imaging
Hyperfine
Neurology AI
Hyperfine's Swoop Portable MR Imaging system is an AI-powered, ultra-low-field MRI device for point-of-care brain imaging, bringing diagnostic-quality scans directly to the patient's bedside.

See all 6 products →

About Hyperfine

Hyperfine, Inc. is a pioneering health technology company dedicated to revolutionizing patient care globally through accessible, clinically relevant diagnostic imaging. Their flagship product, the Swoop® system, is the world’s first FDA-cleared, AI-powered, portable, ultra-low-field magnetic resonance brain imaging system. This innovative technology addresses the significant global challenge of limited MRI access, as conventional MRI systems are often costly, require extensive infrastructure, and are not easily transportable.

The Swoop system is designed for use at the point of care in various professional healthcare settings, including emergency departments, operating rooms (outside the sterile field), intensive care units, and neurology offices. It aims to provide rapid diagnoses and treatment by capturing images in minutes, enabling clinicians to quickly scan, diagnose, and treat patients who may be critically ill or unable to undergo traditional MRI. The system leverages proprietary artificial intelligence, including its Optive AI™ software, to enhance image quality, reduce scan times, and provide advanced features like multi-direction diffusion-weighted imaging (DWI) for improved stroke detection.

Hyperfine’s mission is to democratize healthcare by making MRI accessible to a broader population, regardless of income, resources, or location. The company’s technology is designed for simplified use by trained healthcare professionals, pushing the boundaries of conventional imaging to expand patient access to life-saving care in both mature and emerging healthcare systems.

Focus Areas

Portable MRI ultra-low-field MRI AI-powered diagnostics brain imaging stroke detection neurocritical care emergency medicine pediatrics democratizing healthcare access image-centric computing deep learning

Business Intelligence

Key InvestorsGoogle Ventures (GV), Nextrans, Axiom Associates, Huami, Colle Capital, LSS, Altium Capital, HealthCor Management LP, Catalio Capital Management, Perceptive Advisors, Avidity Partners, Eldridge, ARK Investment Management LLC, Deerfield Management, Bain Capital Public Equity, Gates Foundation, Vanguard Group Inc, Sio Capital Management LLC, Fosun International Ltd, Northern Trust Corp, Alphabet Inc., Geode Capital Management LLC, BlackRock Inc., Jane Street Group LLC, Renaissance Technologies Llc
PartnershipsM Health Fairview University of Minnesota Medical Center, DENT Neurologic Institute, Texas Neurology, Cardiff University Brain Research Imaging Center (CUBRIC)
AcquisitionsMerged with HealthCor Catalio Acquisition Corp and Liminal Sciences, Inc. (business combination, not a traditional acquisition by Hyperfine)
TechnologyUltra-low-field magnetic resonance, proprietary artificial intelligence (AI), deep learning, image-centric computing, Optive AI™ software, Portable Ultra-Low-Field Scientific Exchange (PULSE) platform
FDA ClearancesMultiple, starting in 2020, including software updates and new system generations cleared products (estimated)

What Physicians Need to Know

Core Technology
Hyperfine specializes in portable, ultra-low-field MRI (0.064 Tesla) systems, notably the Swoopu00ae system, which is designed as a scanner-on-wheels. This technology allows MRI capabilities to be brought directly to the patient's bedside.
AI-Powered Diagnostics
The company leverages AI-powered diagnostics, including its proprietary Optive AIu2122 software, which uses deep learning for advanced image reconstruction. This technology enhances image quality by reducing noise and blur, improving clarity, and providing sharper anatomical detail for confident diagnoses.
Clinical Applications
Hyperfine's technology is FDA-cleared for brain imaging across all ages. Key clinical focuses include stroke detection (acute ischemic stroke triage and diagnosis, DWI-FLAIR mismatch), neurocritical care, emergency medicine, and pediatrics (e.g., hydrocephalus, head injury, suspected abuse, post-operative assessment).
Democratizing Healthcare Access
A core mission is to democratize healthcare by making MRI accessible and affordable globally. The portable nature, ability to operate on a standard wall outlet, and elimination of the need for dedicated shielded rooms significantly lower costs and infrastructure requirements, extending advanced imaging to underserved areas and point-of-care settings.
Key Differentiators
Hyperfine stands out due to its system's portability, ultra-low magnetic field, AI-enhanced image quality, and exceptional ease of use (controlled via a tablet, quick setup). Its open design improves patient comfort and reduces anxiety, and it operates without ionizing radiation, offering a safer alternative to CT scans.
Physician Tip

For physicians, Hyperfine's Swoop system offers several critical advantages. It enables **point-of-care imaging**, allowing rapid brain scans directly at the patient's bedside in settings like ICUs and EDs, thereby eliminating the risks and logistical challenges associated with transporting critically ill patients. This leads to **faster diagnosis and intervention**, particularly crucial for time-sensitive conditions like stroke, where timely clinical decisions can significantly impact outcomes. The system's **open design and quieter operation** contribute to a much-improved patient experience, reducing anxiety, especially for pediatric, elderly, or claustrophobic patients, and allowing family presence during scans. Its **accessibility and workflow efficiency** are enhanced by plugging into a standard wall outlet, requiring minimal training for operation, and negating the need for specialized shielded rooms, optimizing MRI resource utilization. Furthermore, being a **radiation-free imaging** modality, it provides a safer option for patients, particularly children requiring serial imaging, compared to CT scans. The **AI-powered software (Optive AIu2122)** ensures enhanced image clarity and diagnostic confidence, even at ultra-low field strengths.

The Hyperfine Swoop system is designed with integration capabilities, allowing it to send DICOM images to local Picture Archiving and Communication Systems (PACS) or Hyperfine's Image Viewer. It can also pull patient information from the Modality Worklist (MWL) to streamline patient registration for exams.

Products by Hyperfine

6 products in the directory

Swoop Point-of-Care Magnetic Resonance Imaging (POC MRI) Scanner
Hyperfine
Neurology AI
The Hyperfine Swoop Point-of-Care (POC) MRI Scanner is the world's first FDA-cleared, portable, ultra-low-field magnetic resonance brain imaging system, bringing diagnostic-quality brain imaging directly to the patient's bedside with AI-powered software.
Swoop® Portable MR Imaging System™
Hyperfine
Neurology AI
The Hyperfine Swoop® Portable MR Imaging System™ is an FDA-cleared, AI-powered, ultra-low-field portable MRI device for brain imaging at the point of care, designed to increase accessibility and facilitate rapid diagnosis in various clinical settings.
Swoop Portable MR Imaging
Hyperfine
Neurology AI
Hyperfine's Swoop Portable MR Imaging system is an AI-powered, ultra-low-field MRI device for point-of-care brain imaging, bringing diagnostic-quality scans directly to the patient's bedside.
Swoop® Portable MR Imaging® System
Hyperfine
Clinical Decision Support & Reference
The Swoop® Portable MR Imaging® System is the world's first and only FDA-cleared portable MRI, enabling point-of-care brain imaging in diverse clinical settings.
Swoop® Portable MR Imaging System®
Hyperfine
Neurology AI
Hyperfine's Swoop® Portable MR Imaging System® is an AI-powered, ultra-low-field MRI device for point-of-care brain imaging, making diagnostics accessible and immediate in various clinical settings.
BrainInsight
Hyperfine
Neurology AI
BrainInsight, Hyperfine's AI-powered software embedded in the Swoop® portable MRI system, automatically assesses brain scans for ventricular volume, brain extraction, brain alignment, and midline shift to aid in diagnosing brain injuries.

What the Web Says

Hyperfine is a health technology company known for its portable MRI system, Swoop, which aims to make brain imaging more accessible. The company has received FDA clearance for its AI-powered portable MRI system and its Optive AI software, which enhances image quality. Reviews indicate a mixed sentiment, with strong enthusiasm for the product's potential to revolutionize healthcare accessibility, but some concerns regarding image quality compared to conventional MRI and the company's financial performance.

Overall: Mixed

Strengths

  • Portable and accessible, allowing MRI scans in various settings like critical care units, emergency departments, and neurology offices.
  • Significantly reduces time from imaging order to scan start compared to conventional MRI.
  • Patients show a strong preference for the portable MRI due to increased comfort, reduced anxiety and claustrophobia, and less noise.
  • Can be operated by existing clinical staff without the need for trained MRI personnel.
  • Lower cost compared to traditional MRI systems, with no significant siting costs.
  • AI-powered software (Optive AI) enhances image quality and assists in interpreting results.

Limitations

  • Image quality may not always match that of conventional high-field MRI scanners, though it is improving.
  • Some early concerns from radiographers about the practicalities and limitations compared to traditional MRI.
  • The company is in a high-growth phase and has been operating at a net loss, though financial metrics are improving.
  • Potential for a learning curve with the system, though support is available.
  • Limited information available on employer reviews from major platforms like Glassdoor and G2, with only a few reviews on SimplyHired and Indeed.

Based on reviews from: SimplyHired, Indeed.com, Reddit, AuntMinnie, Simply Wall St, GlobalData, Hyperfine Inc. Press Releases

Last updated: 2026-07-18

Videos

News, demos, and interviews about Hyperfine.

Loading videos...

Videos load interactively. If none appear, search YouTube for Hyperfine →

View all on YouTube

Press & Coverage

Hyperfine, Inc. Press Releases
Hyperfine Announces European Launch of Next-Generation Swoopu00ae System
Hyperfine has launched its next-generation Swoopu00ae system in European markets, marking a significant step in its global expansion and aiming to improve access to high-quality brain imaging at the point of care.
2026-07
Hyperfine, Inc. Press Releases
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
Hyperfine has established a Global Neurosurgery Advisory Council to guide the integration and expansion of its portable MRI technology in neurosurgical settings, focusing on workflow, product capabilities, and evidence.
2026-06
Hyperfine, Inc. Press Releases
Hyperfine Swoopu00ae System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
Hyperfine announced record scan volumes for its Swoopu00ae system in the U.S., driven by enhanced image quality, expanded clinical utility, and diverse use cases in hospitals and clinics.
2026-06
Morningstar (via Business Wire)
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
Results from the PRIME study, presented at SAEM 2026, demonstrated that Hyperfine's portable MRI significantly reduced the time to imaging for patients in emergency departments.
2026-05
Business Wire
Hyperfine Announces FDA Clearance of Optive AIu2122 Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoopu00ae System
Hyperfine received FDA clearance for its Optive AIu2122 software, which delivers a substantial improvement in image quality for the Swoopu00ae system, enhancing ultra-low-field MR imaging.
2025-05
Hyperfine, Inc. Press Releases
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
Hyperfine received a $3.7 million grant from the Gates Foundation to expand initiatives using AI-powered portable MRI for evaluating childhood brain development and guiding health interventions in underserved communities.
2025-11
Business Wire
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoopu00ae AI-Powered Portable MRI System in Acute Hospital Care
Hyperfine announced a peer-reviewed publication in Clinical Neuroimaging highlighting the positive economic impact of integrating the portable Swoopu00ae MR imaging system in acute hospital care settings.
2026-01
Hyperfine, Inc. Press Releases
Hyperfine Announces $6.0 Million Registered Direct Offering
Hyperfine announced a definitive agreement with investors for a registered direct offering of Class A common stock and warrants, expected to generate approximately $6.0 million in gross proceeds for working capital and general corporate purposes.
2025-02

Frequently Asked Questions

Hyperfine's Swoop is an FDA-cleared, AI-powered, portable, ultra-low-field (0.064T) MRI system designed for brain imaging at the point of care. Unlike conventional high-field MRI, Swoop eliminates the need for patient transport and specialized infrastructure, reducing delays and costs in acute settings. While not a direct replacement, its advanced AI software, Optive AIu2122, enhances image quality and acquisition speed, aiming to provide diagnostic-quality images comparable to higher-field systems for specific clinical questions.
Hyperfine extensively uses AI, primarily through its Optive AIu2122 software, for advanced image reconstruction, noise reduction, and enhanced clarity in ultra-low-field MRI. For stroke detection, the Swoop system, particularly with its next-generation multi-direction DWI sequence, has demonstrated the ability to rapidly and reliably identify small strokes with high sensitivity and specificity, proving valuable in acute care and emergency settings. This AI integration supports timely and confident diagnoses in critical neurological conditions.
The Swoop system is FDA-cleared for brain imaging across all ages, including pediatrics, offering a child-friendly, quieter, and radiation-free option for conditions like hydrocephalus, suspected stroke, and post-operative assessment. Its portability and affordability are crucial for democratizing healthcare access, enabling MRI to be performed at the bedside in critical care, emergency departments, and remote or underserved areas where conventional MRI is often inaccessible or cost-proprohibitive.
The Hyperfine Swoop system has received multiple FDA clearances for its portable MRI device and its AI-powered software, including the latest Optive AIu2122 advancements, for brain imaging in patients of all ages. It also holds CE marking and UKCA approval for its software in European markets. While specific details on patient data security protocols were not explicitly detailed in the provided search results, as an FDA-cleared medical device, it must adhere to stringent regulatory requirements for data privacy and security.
The Swoop system is positioned as a cost-effective solution, with the complete system potentially costing less than the annual service contract for many traditional MRI systems, offering economic benefits through reduced patient transport and wait times. Billing for Swoop scans utilizes the standard CPT code 70551 for brain MRI without contrast. Hyperfine provides ongoing software updates and support, and has launched the subscription-based PULSE platform to empower users with advanced tools for imaging research and innovation.
Hyperfine, a Nasdaq-listed company (HYPR), is expanding its global footprint through strategic distribution partnerships across Europe and Asia, alongside research collaborations in various countries. Recent financial reports indicate positive momentum with increased revenue and extended cash runway into 2028, suggesting improving company stability. These partnerships and financial health support long-term product innovation and sustained support for their AI-powered portable MRI technology.
Hyperfine's image-centric computing approach, powered by deep learning and advanced computing capabilities, differentiates its ultra-low-field MRI by significantly enhancing image quality and reducing scan times. This allows for faster diagnosis, minimizes MRI wait times, and eliminates the logistical challenges of patient transport. The integration of the Swoop system directly into critical care and emergency workflows enables more timely clinical decisions and improves overall patient progression and outcomes.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]

Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]

Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.